[Current chemotherapy in urogenital infections. Part 5:Macrolide antibiotics, carbapenems, monobactams, beta-lactamase inhibitors].
Hofstetter
A
A
Urologische Klinik und Poliklinik, Universität München.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015780:Carbapenems / Q000627:therapeutic use*; D052776:Female Urogenital Diseases / Q000188:drug therapy*; D006801:Humans; D018942:Macrolides; D052801:Male Urogenital Diseases; D008826:Microbial Sensitivity Tests; D008997:Monobactams / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*; D065093:beta-Lactamase Inhibitors
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D018942:Macrolides; D008997:Monobactams; D065093:beta-Lactamase Inhibitors
Aktuelle Chemotherapie bei Urogenitalinfektionen. Folge 5: Makrolidantibiotika, Carbapeneme, Monobactame, Betalactamasehemmer.